Share Capital | 10. SHARE CAPITAL The Company’s authorized share capital consists of an unlimited number of common shares. Number of shares (000’s) $ Year ended December 31, 2020 Opening balance 22,491 114,840 Shares issued on exercise of stock options 261 602 Shares issued on exercise of RSUs and DSUs 382 1,627 Shares issued on exercise of warrants 2 8 Shares issued on acquisition of Otis Gold Corp (1) 8,131 16,370 Shares issued as part of Credit Facility (2) 107 180 Shares issued to settle payables (3) 671 1,738 Value of shares issued in asset acquisition (4) 66 246 Shares issued to settle interest on convertible debentures (5) 228 588 Balance at December 31, 2020 32,339 136,199 Period ended March 31, 2021 Opening balance 32,339 136,199 Shares issued on exercise of stock options 8 27 Shares issued on exercise of RSUs and DSUs 33 137 Balance at March 31, 2021 32,380 136,363 (1) On April 22, 2020, the Company completed the acquisition of Otis. Otis shareholders received 0.046 of a common share for each Otis common share held (the “Exchange Ratio”), resulting in the issuance of 8,130,630 common shares valued at the market price of C$2.85 per common share. (2) On March 16, 2020, the Company closed a US$6-million bridge-loan credit facility (the “Credit Facility”) with Sprott Private Resource Lending II (Collector), LP (“Sprott Lending”). The Credit Facility bore interest of 10% per annum, compounded and payable monthly, and was due and payable in full on or before September 14, 2020. In consideration for the Credit Facility, Excellon issued 107,291 common shares to Sprott Lending. The Company repaid the Credit Facility on August 4, 2020 on the closing of the Financing (Note 9). (3) During the second and third quarters of 2020, the Company issued 670,974 common shares in settlement of certain Otis transaction costs and Mexican trade payables totaling C$2,098, as approved by the TSX. An amount of $196 (C$261) was recorded in other expenses to reflect the difference between the market value of the common shares issued and the carrying amount of the payables settled. (4) On September 21, 2020 and in accordance with the Globex Agreement, the second issuance of 65,657 common shares (valued at C$325) and the second cash payment (C$100) were made and recorded as an addition to mineral rights (Note 6). (5) On December 31, 2020, the Company elected to pay the first interest payment on the Debentures (Note 9) in common shares valued at C$754 ($588). The outstanding number and weighted average exercise prices of equity-settled Stock Options, Warrants, Deferred Share Units (“DSUs”) and Restricted Share Units (“RSUs”) are as follows: Options Warrants Options Outstanding Weighted Average Exercise Price (CAD) Warrants Outstanding (2) Weighted Average Exercise Price (CAD) RSUs Outstanding DSUs Outstanding Outstanding at January 1, 2020 461,000 5.59 1,092,500 7.00 572,485 467,572 Granted/issued/acquired (1) 1,002,395 3.34 1,448,488 5.23 337,331 217,264 Exercised/settled (260,596 ) 1.93 (2,400 ) 3.45 (224,750 ) (193,507 ) Expired (332,359 ) 5.20 - - (91,332 ) - Forfeited (23,004 ) 4.26 - - (128,223 ) - Outstanding at December 31, 2020 847,437 4.21 2,538,588 6.00 465,511 491,330 Exercisable at December 31, 2020 548,009 4.52 2,538,588 6.00 - 98,417 Outstanding at January 1, 2021 847,437 4.21 2,538,588 6.00 465,511 491,330 Granted/issued 212,500 4.14 - - 412,649 110,000 Exercised/settled (7,500 ) 3.05 - - (38,117 ) - Expired (5,000 ) 8.75 - - - - Outstanding at March 31, 2021 1,047,437 4.19 2,538,588 6.00 840,043 601,330 Exercisable at March 31, 2021 631,017 4.49 2,538,588 6.00 - 98,417 (1) On April 22, 2020, the Company issued 531,895 Options and 305,060 Warrants (“$3.30 Warrants”) in replacement of Otis Options and Warrants outstanding at the date of acquiring Otis. In accordance with the Otis Stock Option Plan, 130,365 stock options expired on July 22, 2020, 90 days after the closing of the Transaction. (2) The Company has the following warrants outstanding: ● 1,092,400 warrants with an exercise price of C$7.00, expiring on August 27, 2021; ● 302,760 warrants with an exercise price of C$3.30, expiring on March 29, 2022; and ● 1,143,428 warrants with an exercise price of C$5.75, expiring on July 30, 2023 (Note 9). Options outstanding and exercisable are as follows: Exercise Price Range (CAD) Stock Options Outstanding Weighted Average Remaining Contractual Life (years) Stock Options Exercisable Weighted Average $ 2.00 to $3.99 494,987 2.17 289,860 3.08 $ 4.00 to $5.99 456,450 3.11 245,157 4.62 $ 6.00 to $7.99 15,000 1.16 15,000 7.63 $ 8.00 to $9.99 81,000 1.37 81,000 8.52 1,047,437 2.50 631,017 4.49 Compensation expense is recognized over the vesting period of the grant with the corresponding equity impact recorded in contributed surplus. Share-based compensation expense comprises the following: Three months ended March 31 March 31 2021 2020 $ $ Stock options 203 34 RSU 141 38 DSU 421 77 765 149 |